Search results
Q1 2024 Nektar Therapeutics Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 11 hours agoIn the first quarter, we continued to make significant advancements with our REZPEG program. As you know, we're evaluating REZPEG in a Phase 2b study in moderate to severe atopic< ...
Earnings call: Aclaris Therapeutics progresses with atopic dermatitis study By Investing.com
Investing.com· 2 days ago:ACRS) has announced during its First Quarter 2024 Conference Call that it will advance ATI-2138,...
Here’s What Getting a Skin Patch Test Is Really Like
Self via Yahoo News· 3 days agoAccording to Dr. Silverman, this analysis is a great way to “identify triggers for inflamed rashes caused by eczema.” The most common form of this...
Nektar Therapeutics Reports First Quarter 2024 Financial Results
The West Side Index & Gustine Press-Standard· 1 day agoNektar Therapeutics (Nasdaq: NKTR) today reported financial results for the first quarter ended March 31, 2024. Cash and investments in marketable securities at March 31, 2024 were $326.0 million ...
Managing Comorbidities in Chronic Urticaria
MedPage Today· 2 days agoThe link between chronic urticaria and atopic diseases, autoimmune diseases, and psychiatric disorders has significant implications for clinical practice. Managing comorbidities ...
Childhood eczema could be treated by tailored vaccine: study
WFMZ Eastern Pennsylvania and Western New Jersey· 2 days agoResearchers at Trinity College Dublin believe the jab may be key to treating bacteria-driven...
Q1 2024 Corvus Pharmaceuticals Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 4 days agoSecond, our placebo-controlled Phase 1 trial of so-called fitness for patients with moderate to severe atopic dermatitis. We began patient enrollment in ...
New treatment could reverse hair loss caused by autoimmune skin disease alopecia areata
Medical Xpress· 2 days agoThe team has developed a microneedle patch that can be painlessly applied to the scalp and releases...
I’m 66 and Have Dry Skin Around My Eyes. Will Concealer Help?
The Cut· 15 hours agoQ: I hate to pile on to the never-ending search for under-eye fixes, but I have a question about...
Earnings call: Corvus Pharmaceuticals Q1 2024 financial results and trials update
Investing.com· 4 days agoCorvus Pharmaceuticals, Inc. (NASDAQ: CRVS ) has disclosed its financial outcomes for the first...
